Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.

Saved in:
Bibliographic Details
Title: Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.
Authors: Chen, Huey‐Ling1,2,3 (AUTHOR), Lee, Chien‐Nan4 (AUTHOR), Chang, Chin‐Hao5 (AUTHOR), Lai, Ming‐Wei6,7 (AUTHOR), Tsai, Ming‐Chieh8 (AUTHOR), Mu, Shu‐Chi9 (AUTHOR), Liu, Chun‐Jen3,10,11 (AUTHOR), Shih, Jin‐Chung4 (AUTHOR), Wen, Wan‐Hsin12,13 (AUTHOR), Hu, Rui‐Ting14 (AUTHOR), Huang, Chun‐Pin15 (AUTHOR), Hu, Kuang‐Chun16 (AUTHOR), Chen, Chie‐Pein17 (AUTHOR), Lee, Chyi‐Long18 (AUTHOR), Chien, Rong‐Nan7 (AUTHOR), Chang, Kai‐Chi1 (AUTHOR), Hsu, Hong‐Yuan1,2 (AUTHOR), Lee, Chien‐Chang19,20 (AUTHOR), Ni, Yen‐Hsuan1,3 (AUTHOR), Chang, Mei‐Hwei1,3 (AUTHOR) changmh@ntu.edu.tw
Source: Liver International. Jun2024, Vol. 44 Issue 6, p1422-1434. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14783223
DOI:10.1111/liv.15873